CHE vs K · P/E 24, rev $2.43B vs P/E 23, $29.03B cap
Chemed Corp (CHE) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
K does not have a complete income-statement cache yet.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CHE and K stock pages for the full models.
Not investment advice.